Lv3
240 积分 2022-12-05 加入
我国小核酸药物研发与注册的相关问题研究
5个月前
已完结
Current Advances in the Treatment of BRAF-Mutant Melanoma
9个月前
已完结
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial. Lancet Oncol. 2017;18(10):1307-1316
9个月前
已完结
An open-label phase 2 trial of dabrafenib plus trametinib in patients with p
9个月前
已完结
Advances in anti-BRAF therapies for lung cancer
9个月前
已关闭
皖公网安备34019202002308